SCHEMBL22272155

SCHEMBL22272155

C=C(C=O)CNc1cccc(C(=O)N2CCC(C(=O)Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)CC2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 17/20 0.64
▸ CDK9 P50750 12/20 0.64
▸ CDK7 P50613 10/20 0.64
▸ CCNT1 O60563 4/20 0.64
▸ CCNH P51946 4/20 0.64
▸ MNAT1 P51948 4/20 0.64
▸ CCNA1 P78396 4/20 0.64
▸ CCNE2 O96020 6/20 0.61
▸ CCNE1 P24864 6/20 0.61
▸ CDK4 P11802 2/20 0.57
▸ CCND1 P24385 2/20 0.57
▸ CIT O14578 1/20 0.57
▸ CASK O14936 1/20 0.57
▸ AURKA O14965 1/20 0.57
▸ GAK O14976 1/20 0.57
▸ DCLK1 O15075 1/20 0.57
▸ MAP3K7 O43318 1/20 0.57
▸ ULK1 O75385 1/20 0.57
▸ RPS6KA5 O75582 1/20 0.57
▸ PAK3 O75914 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17148352 0.89 CDK2 (0.76) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL22272115 0.86 CDK2 (0.67) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL17148348 0.81 CDK2 (0.84) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL21128620 0.81 CDK2 (0.71) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL20583163 0.80 CDK2 (0.85) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL17141895 0.79 CDK2 (1.00) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL22272062 0.78 CDK2 (0.81) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL17141859 0.77 CDK2 (0.95) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL20905302 0.77 CDK2 (1.00) CDK2CDK9CDK7CCNT1CCNH
SCHEMBL24758127 0.77 CDK2 (0.79) CDK2CDK9CDK7CCNT1CCNH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3129371-B1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS INC (US) 2020-07-29 — — EP disclosed
Send feedback